NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $15,433,000 | +37.6% | 431,475 | -0.0% | 5.92% | +34.5% |
| Q3 2014 | $11,219,000 | -21.3% | 431,525 | +0.0% | 4.40% | -13.7% |
| Q2 2014 | $14,255,000 | +12.3% | 431,325 | +1.7% | 5.10% | +0.8% |
| Q1 2014 | $12,695,000 | -23.9% | 424,175 | -22.8% | 5.06% | -26.5% |
| Q4 2013 | $16,680,000 | +0.2% | 549,425 | +5.0% | 6.89% | -18.5% |
| Q3 2013 | $16,642,000 | +4.1% | 523,200 | -50.5% | 8.45% | +70.4% |
| Q2 2013 | $15,982,000 | – | 1,057,800 | – | 4.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|